Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast

Leek, R.D.; Landers, R.J.; Harris, A.L.; Lewis, C.E.
February 1999
British Journal of Cancer;2/15/99, Vol. 79 Issue 5/6, p991
Academic Journal
Necrosis is a common feature of invasive carcinoma of the breast and is caused by chronic ischaemia leading to infarction. Although necrosis was previously assumed to be due to a generally poor blood supply in the tumour, in this study we show that it is present in tumours with focal areas of high vascular density situated away from the actual sites of necrosis. This may account, in part, for the previous observation that necrosis is linked to poor prognosis in this disease. Highly angiogenic tumours often display blood vessel shunting from one tumour area to another, which further exacerbates ischaemia and the formation of tumour necrosis. We have recently demonstrated that high focal microphage infiltration into breast tumours is significantly associated with increased tumour angiogenesis and poor prognosis and that the macrophages accumulate in poorly vascularized, hypoxic areas within breast tumours. In order to investigate the interactions of macrophages with chronic ischaemia (as reflected by the presence of necrosis) and angiogenesis in breast tumours, we quantified the levels of these three biological parameters in a series of 109 consecutive invasive breast carcinomas. We found that the degree of tumour necrosis was correlated with both microphage infiltration (Mann–Whitney U, P-value = 0.0009; chi-square, P-value = 0.01) and angiogenesis (Mann–Whitney U P-value = 0.0008, chi square P-value = 0.03). It was also observed that necrosis was a feature of tumours possessing an aggressive phenotype, i.e. high tumour grade (chi-square, P-value < 0.001), larger size (Mann–Whitney U, P-value = 0.003) and low oestrogen receptor status (Mann–Whitney U, P-value = 0.008; chi-square, P-value < 0.008). We suggest, therefore, that aggressive tumours rapidly outgrow their vascular supply in certain areas, leading to areas of prolonged hypoxia within the tumour and, subsequently, to necrosis. This, in turn, may attract macrophages into the tumour, which then contribute to the angiogenic process, giving rise to an association between high levels of angiogenesis and extensive necrosis. © 1999 Cancer Research Campaign


Related Articles

  • Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Cai, Zhenzi; Capoulade, Corinne; Moyret-Lalle, Caroline; Amor-Gueret, Mounira; Feunteun, Jean; Larsen, Annette K; Paillerets, Brigitte Bressac-de; Chouaib, Salem // Oncogene;12/04/97, Vol. 15 Issue 23, p2817 

    We have investigated the relationship between the development of tumor resistance towards the cytotoxic action of tumor necrosis factor-α (TNF) and p53 function, using the TNF-sensitive MCF7 human breast adenocarcinoma cell line and two TNF-resistant sublines, MCF7/R-A1 and MCF7/Adr. Use of...

  • Higher sTNF-RII Associated with Reduced Memory Functioning Among BC Patients Before Treatment. Patel, Sunita K.; Bovbjerg, Dana H. // JNCI: Journal of the National Cancer Institute;8/12/2015, Vol. 107 Issue 8, p1 

    The article offers insight on research about the reduced memory functioning-associated soluble TNF receptor type two (sTNF-RII) among breast cancer (BC) patients. Topics discussed include the association between neurocognitive dysfunction and pro-inflammatory cytokines in BC patients, the...

  • Adalimumab/etanercept/infliximab.  // Reactions Weekly;5/25/2013, Issue 1454, p5 

    An abstract of the article "Patch testing for the diagnosis of adverse reactions to tumor necrosis alpha inhibitors," by L. Di Costanzo and colleagues is presented.

  • Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. Stanford, Jamie C.; Young, Christian; Hicks, Donna; Owens, Philip; Williams, Andrew; Vaught, David B.; Morrison, Meghan M.; Jiyeon Lim; Williams, Michelle; Brantley-Sieders, Dana M.; Balko, Justin M.; Tonetti, Debra; Earp III, H. Shelton; Cook, Rebecca S. // Journal of Clinical Investigation;Nov2014, Vol. 124 Issue 11, p4737 

    Breast cancers that occur in women 2-5 years postpartum are more frequently diagnosed at metastatic stages and correlate with poorer outcomes compared with breast cancers diagnosed in young, premenopausal women. The molecular mechanisms underlying the malignant severity associated with...

  • Timp3 Deficient Mice Show Resistance to Developing Breast Cancer. Jackson, Hartland W.; Hojilla, Carlo V.; Weiss, Ashley; Sanchez, Otto H.; Wood, Geoffrey A.; Khokha, Rama // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Timp3 is commonly silenced in breast cancer, but mechanistic studies have identified both tumor promotion and suppression effects of this gene. We have taken a genetic approach to determine the impact of Timp3 loss on two mouse models of breast cancer. Interestingly, MMTV-PyMT...

  • Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors. Herrnring, Christina; Reimer, Toraif; Jeschke, Udo; Makovitzky, Josef; Krüger, Karolin; Gerber, Bernd; Kabelitz, Dieter; Friese, Klaus // Histochemistry & Cell Biology;Mar2000, Vol. 113 Issue 3, p189 

    Apoptosis-inducing ligands such as Fas ligand (FasL) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) have been found to play an important role in cell regulation. Different malignant tumors show an altered expression of these ligands and their respective receptors compared to...

  • Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling. Sundararajan, Ramya; Guanghua Chen; Mukherjee, Chandreyee; White, Eileen // Oncogene;7/21/2005, Vol. 24 Issue 31, p4908 

    Deleted in breast cancer-1 (DBC-1) was initially cloned from a homozygously deleted region in breast and other cancers on human chromosome 8p21, although no function is known for the protein product it encodes. We identified the generation of amino-terminally truncated versions of DBC-1 during...

  • Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro. Zhicheng Ge; Sanders, Andrew J.; Lin Ye; Yu Wang; Jiang, Wen G. // Journal of Experimental Therapeutics & Oncology;2011, Vol. 9 Issue 2, p109 

    Background: Death Decoy Receptor-3 (DcR3), otherwise known as tumour necrosis factor receptor superfamily member 6b, is suggested to be involved in the progression and immune evasion of malignant tumours. Its ligands include FASL and LIGHT (Tumour necrosis factor ligand superfamily member 14)....

  • Erbin-regulated Sensitivity of MCF-7 Breast Cancer Cells to TRAIL via ErbB2/AKT/NF-κB Pathway. Ning Liu; Jindan Zhang; Jinchun Zhang; Shilian Liu; Yanxin Liu; Dexian Zheng // Journal of Biochemistry;Jun2008, Vol. 143 Issue 6, p793 

    We have reported that Erbin expression was down-regulated in the Jurkat leukaemia T lymphocytes treated with the recombinant soluble tumour necrosis factor-related apoptosis-inducing ligand (rsTRAIL). Herein, we studied the expression and the regulation of Erbin and its binding partner, ErbB2,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics